You are here

  • Home
  • Archive
  • Volume 14, Issue 1
  • Review: postmenopausal hormone therapy increases risk of stroke and venous thromboembolism but not coronary heart disease events

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: postmenopausal hormone therapy increases risk of stroke and venous thromboembolism but not coronary heart disease events

https://doi.org/10.1136/ebm.14.1.18

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    P M Bath

    Dr P M Bath, University of Nottingham, Nottingham, UK; philip.bath@nottingham.ac.uk

    QUESTION

    What are the effects of hormone therapy (HT) on arterial and venous vascular events in postmenopausal women?

    REVIEW SCOPE

    Included studies compared risk of vascular events in postmenopausal women receiving HT with that of women receiving placebo or no HT. Outcomes were cerebrovascular disease events (stroke or transient ischaemic attack), coronary heart disease (CHD) events (myocardial infarction, sudden cardiac death, or unstable angina), and venous thromboembolic (VTE) disease events (deep venous thrombosis, pulmonary embolism, or cerebral sinus thrombosis).

    REVIEW METHODS

    Cochrane Library, Medline, PubMed, and EMBASE/Excerpta Medica (to Jan 2008); and reference lists were searched for randomised controlled trials (RCTs) published in English. 31 trials (n = 44 113, mean age 47–75 y) met the selection criteria. Duration of …

    View Full Text

    Footnotes

    • Source of funding: no external funding.